Crossmark

Treatment potential of pathogen-reactive antibodies sequentially purified from pooled human immunoglobulin

Published Online: 2019-04-15

Published Print: 2019-12

Authors

Reglinski, Mark

Sriskandan, Shiranee https://orcid.org/0000-0002-5214-4941
Funding

Funding for this research was provided by:

United Kingdom Clinical Research Collaboration (G0800777)

Medical Research Council (Confidence in Concept)

National Institute for Health Research (HPRU-2012-10047)
License Information

Text and Data Mining valid from 2019-04-15
More Information

Article History

Received: 5 March 2019

Accepted: 6 April 2019

First Online: 15 April 2019

Document is current